Abstract
Streptococcus pneumoniae is responsible for lower-respiratory-tract infections in humans and also the most common cause of otitis media (bacterial middle ear infection) in children. Pneumococcal pneumonia is rarely a primary infection of the lung but such factors as damage to the respiratory tract, fatigue, chilling of the body and general debilitation predispose to infection. S. pneumoniae can be isolated from the pharynx of 30–70% of apparently normal humans.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amsbaugh, D.F., Hansen, C.T., Prescott, B., Stashak, P.W., Barthold, D.R. and Baker, P.J., 1972, Genetic control of the antibody response to type III pneumococcal polysaccharide in mice. I. Evidence that an X-linked gene plays a decisive role in determining responsiveness, J.Exp.Med., 136: 931.
Aplin, J.D. and Wriston, J.C., 1981, Preparation, properties, and applications of carbohydrate conjugates of proteins and lipids, C.R.C. Crit.Rev.Biochem., 5: 295.
Austrian, R., 1981, Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention, Rev.Infect.Dis., 3: S1.
Baker, P.J., Stashak, P.W. and Prescott, B., 1969, Use of erythrocytes sensitized with purified pneumococcal polysaccharide for the assay of antibody and antibody-producing cells, Appl.Microbiol., 17: 422.
Björk, I., Larm, O., Lindberg, U., Norling, K. and Riquelme, M-E., 1982, Permanent activation of antithrombin by covalent attachment of heparin oligosaccharides, FEBS Lett., 143: 96.
Campbell, J.H. and Pappenheimer, A.M., 1966, Quantitative studies of the specificity of anti-pneumococcal polysaccharide antibodies types III and VIII. I. Isolation of oligosaccharides from acid and from enzymic hydrolysates, Immunochemistry, 3: 195.
Chernyak, A.Y., Antonov, K.V., Kochetkov, N.K., Padyukov, L.N. and Tsvetkova N.V., 1985, Two synthetic antigens related to Streptococcus pneumoniae type 3 capsular polysaccharide, Carbohydr.Res., 141: 199.
Defaye, J., 1970, 2,5-Anhydrides of sugars and related compounds, Adv. Carbohydr.Chem.Biochem., 25: 181.
Erbing, C., Lindberg, B. and Svensson, S., 1979, Deamination of methyl 2-amino-2-deoxy-a-and-b-D-glucopyranosides, Acta Chem.Scand., 27: 3699.
Finland, M., 1978, And the walls come tumbling down. More antibiotic resistance, and now the pneumococcus, N.Engl.J.Med., 299: 770.
Fogler, W.E., Swartz, G.M. and Alving, C.R., 1987. Antibodies to phospholipids and liposomes: binding of antibodies to cells, Biochim. Biophys.Acta, 903: 265.
Gigg, R., 1980, Synthesis of glycolipids, Chem.Phys.Lipids, 26: 287.
Goebel, W.F., 1940, Studies on antibacterial immunity induced by artificial antigen II immunity to experimental pneumococcal infection with an antigen-containing cellobiuronic acid, J.Exp.Med., 69: 353.
Gosh, P., Bachkawat, B.K. and Surolia, A., 1981, Synthetic glycolipids: interaction with galactose-binding lectin and hepatic cells, Arch. Biochem.Biophys., 206: 454.
Health and Public Policy Committee (Am. Coll. Phys.) 1986, Pneumococcal vaccine, Ann.Int.Med., 104: 118.
Hilgers, L.A.T., 1986, Immunomodulating properties of synthetic adjuvants, Thesis, R.U. Utrecht.
Hoagland, P.D., Pfeffer, P.E. and Valentine, K.M., 1979, Reductive amination of lactose: unusual 13C-n.m.r. spectroscopic properties of N-alkyl(l-deoxy-lactitol-lyl)amines, Carbohydr.Res., 74: 135.
Hoffman, J., Larm, O. and Schollander, E., 1983, A new method for covalent coupling of heparin and other glycosaminoglycans to substances containing primary aminogroups, Carbohydr.Res., 117: 328.
Horton, D. and Phillips, K.D., 1979, The nitrous acid deamination of glycosides and acetates of 2-amino-2-deoxy-D-glucose, Carbohydr.Res., 30: 367.
Hotchkiss, R.D. and Goebel, W.F., 1937, Chemo-immunological studies on the soluble specific substance of Pneumococcus. III. The structure of aldobionic acid from the type III polysaccharide, J. Biol.Chem., 121: 195.
Hunter, R.L. and Bennett, B., 1984, The adjuvant activity of nonionic block polymer surfactants. II. Antibody formation and inflammation related to the structure of triblock and octablock copolymers, J. Immunol., 133: 3167.
Jennings, H.J., 1983, Capsular polysaccharides as human vaccines, Adv. Carbohydr.Chem.Biochem., 41: 155.
Kabat, E.A., 1960, The upper limit for the size of the human antidextran combining site, J. Immunol., 84: 82.
Kamerling, J.P., Gerwig, G.J. and Vliegenthart, J.F.G., 1975, Characterization by gas-liquid chromatography-mass spectrometry and proton magnetic resonance spectroscopy of pertrimethylsilyl methyl glycosides obtained in the methanolysis of glycoproteins and glycopeptides, Biochem.J., 151: 491.
Kaufmann, F., Lund, E. and Eddy, B.E., 1960, Proposal for a change in the nomenclature of Diplococcus pneumoniae and a comparison of the Danish and American type designations, Int.Bull.Bacteriol.Nomencl.Taxon., 10: 31.
Kenne, L. and Lindberg, B., 1983, Bacterial polysaccharides, in: “The Polysaccharides”, Vol. 2, G.O. Aspinall, ed., Academic Press.
Larm, O. and Lindberg, B., 1976, The pneumococcal polysaccharides, a reexamination, Adv.Carbohydr.Chem.Biochem., 33: 295.
Lindberg, B., Lnngren, J. and Powell, D.A., 1977, Structural studies on the specific type-14 pneumococcal polysaccharide, Carbohydr.Res., 58: 177.
Proctor, R.A., 1984, “Handbook of Endotoxin”, Vol. 1, Chemistry of Endotoxin, E.Th. Rietschel, ed., Elsevier, Amsterdam.
Read, B.D., Demel, R.A., Wiegandt, H. and Van Deenen, L.L.M., 1977, Specific interaction of concanavalin A with glycolipid monolayers, Biochim. Biophys.Acta, 470: 325.
Reed, L.J. and Muench, H., 1938, A simple method for estimating fifty percent endpoints, Am.J.Hyg., 27: 493.
Robbins, J.B., 1978, Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future, Immunochemistry, 15: 839.
Robbins, J.B., Austrian, R., Lee, C-J., Rastogi, S.C., Schiffman, G., Henrichsen, J., Mkel, P.H., Broome, C.V., Facklam, R.R., Tiesjema, R.H. and Parke, J-C., 1983, Considerations for formulating the second-generation pneumococcal capsular-polysaccharide vaccine with emphasis on the cross-reactive types within groups, J.Infect.Dis., 148: 1136.
Scher, I., 1982, The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity, Adv.Immunol., 33: 1.
Snippe, H., Van Houte, A.J., Van Dam, J.E.G., de Reuver, M.J., Jansze, M. and Willers, J.M.N., 1983a, Immunogenic properties in mice of hexasaccharide from the capsular polysaccharide of Streptococcus pneumoniae type 3, Infect.Immun., 40: 856.
Snippe, H., Van Dam, J.E.G., Van Houte, A.J., Willers, J.M.N., Kamerling, J.P. and Vliegenthart, J.F.G., 1983b, Preparation of a semisynthetic vaccine to Streptococcus pneumoniae type 3, Infect.Immun., 42: 842.
Snippe, H., Zigterman, J.W.J., Van Dam, J.E.G. and Kemerling, J.P., 1988, Oligosaccharide-haptenated liposomes used as a vaccine to Streptococcus pneumoniae, in: “Liposomes as Drug Carriers”, G. Gregoriadis, ed., J. Wiley & Sons Ltd., Chichester.
Stowell, C.P. and Lee, Y.C., 1980, Neoglycoproteins, the preparation and application of synthetic glycoproteins, Adv.Carbohydr.Chem.Biochem., 37: 225.
Svenson, S.B. and Lindberg, A.A., 1978, Immunochemistry of Salmonella O-antigens. Preparation of an octasaccharide-bovine serum albumin immunogen representative of Salmonella serogroup B O-antigen and characterization of the antibody response, J. Immunol., 120: 1750.
Tsai, C.S., 1970, Determination of the degree of polymerization of N-acetyl chitooligoses by chromatographic methods, Anal. Biochem., 36: 114.
Uemera, K., Nicolotti, R.A., Six, H.R. and Kinskey, S.C., 1974, Antibody formation in response to liposomal membranes sensitized with N-substituted phosphatidyl ethanolamine derivatives, Biochemistry, 13: 1572.
Van Houte, A.J., Snippe, H. and Willers, J.M.N., 1979, Characterization of immunogenic properties of haptenated liposomal model membranes in mice. I. Thymus independence of the antigen, Immunology, 37: 505.
Wiegandt, H. and Ziegler, W., 1974, The use of reductaminated sugars for the preparation of oligosaccharide conjugates. I. Synthetic glycolipids containing glycosphingolipid-derived oligosaccharides, Hoppe-Seyler’s Z.Physiol.Chem., 355: 11.
Williams, T.J., Plessas, N.R., Goldstein, I.J. and Lnngren, J., 1979, A new class of model glycolipids: synthesis, characterization, and interaction with lectins, Arch.Biochem.Biophys., 195: 145.
Wood, C. and Kabat, E.A., 1981a, Immunochemical studies of conjugates of isomaltosyl oligosaccharide to lipid. I. Antigenicity of the glycolipids and the production of specific antibodies in rabbits, J.Exp.Med., 154: 432.
Wood, C. and Kabat, E.A., 1981b, Immunochemical studies of conjugates of isomaltosyl oligosaccharide to lipid. II. Specificities and reactivities of the antibodies formed in rabbits to stearylisomaltosyl oligosaccharides, Arch.Biochem.Biophys., 212: 262.
Wood, C. and Kabat, E.A., 1981c, Immunochemical studies of conjugates of isomaltosyl oligosaccharide to lipid. III. Fractionation of rabbit antibodies to stearyl-isomaltosyl oligosaccharides and a study of their combining sites by a competitive binding assay, Arch.Biochem. Biophys., 212: 277.
Zigterman, J.W.J., Van Dam, J.E.G., Snippe, H., Rotteveel, F.T.M., Jansze, M., Willers, J.M.N., Kamerling, J.P. and Vliegenthart, J.F.G., 1985, Immunogenic properties of octasaccharide-protein conjugates derived from Klebsiella serotype II capsular polysaccharide, Infect.Immun., 47: 421.
Zigterman, J.W.J., Snippe, H., Jansze, M. and Willers, J.M.N., 1987, Adjuvant effects of nonionic block polymer surfactants on liposome induced humoral immune response, J. Immunol., 138: 220.
Zigterman, J.W.J., Verheul, A.F.M., Ernste, E.B.H.W., Rombouts, R.F.M., de Reuver, M.J., Jansze, M., Snippe, H. and Willers, J.M.N., 1988, Measurement of the humoral immune response against Streptococcus pneumoniae type 3 capsular polysaccharide and oligosaccharide containing antigens by ELISA and ELISPOT techniques, J. Immunol.Meth., 106: 101.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Snippe, H., Verheul, A.F.M., van Dam, J.E.G. (1989). Liposomal Vaccine to Streptococcus Pneumoniae Type 3 and 14. In: Gregoriadis, G., Allison, A.C., Poste, G. (eds) Immunological Adjuvants and Vaccines. NATO ASI Series, vol 179. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-0283-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-4757-0283-5_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-0285-9
Online ISBN: 978-1-4757-0283-5
eBook Packages: Springer Book Archive